Will a commercial application of sunlight-induced quantum entanglement be announced by August 1, 2027?

This market resolves to Yes if during COP31, which is scheduled for November 2026, a major participating country or coalition announces a new substantial climate policy specifically addressing the recent acceleration in global warming, as reported by the Potsdam Institute for Climate Impact Research. The policy must be officially announced and publicly verified during the conference dates.

This market resolves to Yes if an official report states that the global average temperature has reached or exceeded 1.5°C above pre-industrial levels by December 31, 2027. This is based on data from leading climate monitoring organizations such as NASA, NOAA, or the IPCC.

This market resolves to Yes if the National Science Foundation announces the continuation or expansion of their new Ph.D. model program by August 1, 2028, indicating it has met or exceeded its objectives outlined in the pilot phase.

This market resolves to Yes if the AI-discovered natural molecule identified by Stanford scientists as having Ozempic-like effects without typical side effects receives FDA approval by July 31, 2027. The market resolves to No if approval has not been granted by this date.

This market resolves to Yes if Stanford Medicine or another reputable institution publicly confirms that the AI-discovered molecule, which mimics the effects of Ozempic without the side effects, receives approval to commence clinical trials by September 30, 2026. The resolution will be based on announcements from institutions, regulatory bodies, or credible science news sources.

This market resolves to Yes if any official regulatory body approves the AI-discovered natural molecule for weight loss treatment by December 31, 2026. This molecule is designed to mimic Ozempic-like effects without the side effects, as reported in recent research from Stanford scientists.